Add Your Blog | | Signup
Truth on the Market · 1d ago

Fair use’s fatal conceit

My colleague, Neil Turkewitz, begins his fine post for Fair Use Week (read: crashing Fair Use Week) by noting that Many of the organizations celebrating fair use would have you believe, beca...
Truth on the Market · 1W ago

Legatum Institute’s Special Trade Commission Advances Brexit Policies Designed to Promote Economic Freedom and Prosperity – for the United Kingdom and (Eventually) the World

The Legatum Institute (Legatum) is “an international think tank based in London and a registered UK charity [that] . . . focuses on understanding, measuring, and explaining the journey from ...
Truth on the Market · 1W ago

How to Regulate: Externalities

Following is the second in a series of posts on my forthcoming book, How to Regulate: A Guide for Policy Makers (Cambridge Univ. Press 2017).  The initial post is here. As I mentioned in my ...
Truth on the Market · 2W ago

The song remains the same: Exceptionalists against the application of the law

In a recent article for the San Francisco Daily Journal I examine Google v. Equustek: a case currently before the Canadian Supreme Court involving the scope of jurisdiction of Canadian court...
Truth on the Market · 3W ago

ABA Antitrust Section Transition Report: A Respectful Critique

The American Bar Association Antitrust Section’s Presidential Transition Report (“Report”), released on January 24, provides a helpful practitioners’ perspective on the state of federal anti...
Truth on the Market · 3W ago

How to Regulate: An Overview

So I’ve just finished writing a book (hence the reason for my long hiatus from Truth on the Market).  Now that the draft is out of my hands and with the publisher (Cambridge University Press...
Truth on the Market · 4W ago

Commissioner Ohlhausen’s Qualcomm Dissent Points the Way Toward Sound Antitrust Enforcement

The Federal Trade Commission’s (FTC) regrettable January 17 filing of a federal court injunctive action against Qualcomm, in the waning days of the Obama Administration, is a blow to its ins...
Truth on the Market · 1M ago

Understanding government negotiation of Medicare drug prices

In a weekend interview with the Washington Post, Donald Trump vowed to force drug companies to negotiate directly with the government on prices in Medicare and Medicaid.  It’s unclear what, ...
Truth on the Market · 1M ago

FTC Economists’ Paper Discredits Claims of Inappropriately “Weak” Merger Enforcement

During 2016 it became fashionable in certain circles to decry “lax” merger enforcement and to call for a more aggressive merger enforcement policy (see, for example, the American Antitrust I...
Truth on the Market · 1M ago

What Will Trump Antitrust Be Like? Come to Heritage on January 24 and Find Out

During a presidential transition, it is an old Washington parlor game to discuss public policy tweaks and personnel changes, with speculation often focusing on former political appointees wh...